What Researchers Did
Researchers conducted a prospective observational pilot study to assess the safety and tolerability of hyperbaric oxygen therapy (HBO) as an adjunct to IVF in women with a poor prognosis for pregnancy.
What They Found
The study found that hyperbaric oxygen therapy was well tolerated by women undergoing IVF treatment. However, the researchers concluded that further study is required to determine its efficacy as an adjuvant therapy, as no specific outcome improvements were quantified.
What This Means for Canadian Patients
Canadian patients undergoing IVF might consider hyperbaric oxygen therapy as a well-tolerated adjunct, but its effectiveness in improving pregnancy outcomes is not yet established. Further research is needed before this therapy can be routinely recommended to improve IVF success rates.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
A limitation of this pilot study is its inability to definitively determine the efficacy of hyperbaric oxygen therapy as an adjuvant to IVF.